Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Return on Assets (2020 - 2025)

Benitec Biopharma has reported Return on Assets over the past 6 years, most recently at 0.0% for Q4 2025.

  • Quarterly results put Return on Assets at 0.0% for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was 0.0% (changed 0.0% YoY), and the annual figure for FY2025 was 0.01%, changed 0.0%.
  • Return on Assets reached 0.0% in Q4 2025 per BNTC's latest filing, up from 0.0% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.0% in Q1 2025 and bottomed at 0.03% in Q2 2023.
  • Median Return on Assets over the past 5 years was 0.01% (2021), compared with a mean of 0.01%.
  • The largest annual shift saw Return on Assets fell -1bps in 2022 before it grew 2bps in 2024.
  • Over 5 years, Return on Assets stood at 0.01% in 2021, then dropped by -13bps to 0.01% in 2022, then grew by 27bps to 0.01% in 2023, then soared by 77bps to 0.0% in 2024, then decreased by -14bps to 0.0% in 2025.
  • Business Quant data shows Return on Assets for BNTC at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.